136 related articles for article (PubMed ID: 38615609)
41. ANGPTL3 deficiency impairs lipoprotein production and produces adaptive changes in hepatic lipid metabolism.
Burks KH; Xie Y; Gildea M; Jung IH; Mukherjee S; Lee P; Pudupakkam U; Wagoner R; Patel V; Santana K; Alisio A; Goldberg IJ; Finck BN; Fisher EA; Davidson NO; Stitziel NO
J Lipid Res; 2024 Feb; 65(2):100500. PubMed ID: 38219820
[TBL] [Abstract][Full Text] [Related]
42. Undaria pinnatifida soluble fiber regulates Angptl3-LPL pathway to lessen hyperlipidemia in mice.
Xiao HB; Lu XY; Zhang HB; Sun ZL; Fang J
J Physiol Biochem; 2013 Dec; 69(4):719-25. PubMed ID: 23595961
[TBL] [Abstract][Full Text] [Related]
43. Relationship between Serum Angiopoietin-like Proteins 3 and 8 and Atherogenic Lipid Biomarkers in Non-Diabetic Adults Depends on Gender and Obesity.
Murawska K; Krintus M; Kuligowska-Prusinska M; Szternel L; Stefanska A; Sypniewska G
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959891
[TBL] [Abstract][Full Text] [Related]
44. ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition.
Chen YQ; Pottanat TG; Zhen EY; Siegel RW; Ehsani M; Qian YW; Konrad RJ
J Lipid Res; 2021; 62():100068. PubMed ID: 33762177
[TBL] [Abstract][Full Text] [Related]
45. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
[TBL] [Abstract][Full Text] [Related]
46. AMPK-SIRT1-independent inhibition of ANGPTL3 gene expression is a potential lipid-lowering mechanism of metformin.
Lin L; Burke J; Venkatesh S; Sadana P
J Pharm Pharmacol; 2019 Sep; 71(9):1421-1428. PubMed ID: 31273790
[TBL] [Abstract][Full Text] [Related]
47. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
Jin SH; Yang JH; Shin BY; Seo K; Shin SM; Cho IJ; Ki SH
Toxicol Appl Pharmacol; 2013 Aug; 271(1):95-105. PubMed ID: 23651738
[TBL] [Abstract][Full Text] [Related]
48. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance.
Haller JF; Mintah IJ; Shihanian LM; Stevis P; Buckler D; Alexa-Braun CA; Kleiner S; Banfi S; Cohen JC; Hobbs HH; Yancopoulos GD; Murphy AJ; Gusarova V; Gromada J
J Lipid Res; 2017 Jun; 58(6):1166-1173. PubMed ID: 28413163
[TBL] [Abstract][Full Text] [Related]
49. Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.
Sylvers-Davie KL; Davies BSJ
Am J Physiol Endocrinol Metab; 2021 Oct; 321(4):E493-E508. PubMed ID: 34338039
[TBL] [Abstract][Full Text] [Related]
50. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.
Shimizugawa T; Ono M; Shimamura M; Yoshida K; Ando Y; Koishi R; Ueda K; Inaba T; Minekura H; Kohama T; Furukawa H
J Biol Chem; 2002 Sep; 277(37):33742-8. PubMed ID: 12097324
[TBL] [Abstract][Full Text] [Related]
51. Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines.
Delmulle L; Bellahcène A; Dhooge W; Comhaire F; Roelens F; Huvaere K; Heyerick A; Castronovo V; De Keukeleire D
Phytomedicine; 2006 Nov; 13(9-10):732-4. PubMed ID: 16678392
[TBL] [Abstract][Full Text] [Related]
52. Beneficial effect of xanthoangelol, a chalcone compound from Angelica keiskei, on lipid metabolism in stroke-prone spontaneously hypertensive rats.
Ogawa H; Okada Y; Kamisako T; Baba K
Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):238-43. PubMed ID: 17250645
[TBL] [Abstract][Full Text] [Related]
53. ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis.
Mohamed F; Mansfield BS; Raal FJ
Curr Atheroscler Rep; 2022 Dec; 24(12):959-967. PubMed ID: 36367663
[TBL] [Abstract][Full Text] [Related]
54. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms.
Shan L; Yu XC; Liu Z; Hu Y; Sturgis LT; Miranda ML; Liu Q
J Biol Chem; 2009 Jan; 284(3):1419-24. PubMed ID: 19028676
[TBL] [Abstract][Full Text] [Related]
55. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
[TBL] [Abstract][Full Text] [Related]
56. Regulation of triglyceride metabolism by Angiopoietin-like proteins.
Mattijssen F; Kersten S
Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269
[TBL] [Abstract][Full Text] [Related]
57. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice.
Ando Y; Shimizugawa T; Takeshita S; Ono M; Shimamura M; Koishi R; Furukawa H
J Lipid Res; 2003 Jun; 44(6):1216-23. PubMed ID: 12671033
[TBL] [Abstract][Full Text] [Related]
58. Regulation of the human lipoprotein lipase gene by the forkhead box transcription factor FOXA2/HNF-3β in hepatic cells.
Kanaki M; Kardassis D
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):327-336. PubMed ID: 28126606
[TBL] [Abstract][Full Text] [Related]
59. Regulation of the angiopoietin-like protein 3 gene by LXR.
Kaplan R; Zhang T; Hernandez M; Gan FX; Wright SD; Waters MG; Cai TQ
J Lipid Res; 2003 Jan; 44(1):136-43. PubMed ID: 12518032
[TBL] [Abstract][Full Text] [Related]
60. Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism.
Kersten S
J Lipid Res; 2021; 62():100150. PubMed ID: 34801488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
